no clinical data yet on psychiatric or addiction effects
This reflects a broader industry reality: large pharma companies may prefer acquiring differentiated platforms rather than building from zero in an increasingly crowded race
First study author Michael Corley, PhD, associate professor of medicine in the Division of Geriatrics, Gerontology & Palliative Care at UC San Diego School of Medicine and the Stein Institute for Research on Aging, spoke to Medical News Today about the study findings
This review provides an overview of the epidemiology, diagnosis, screening, and prevention of T2D, with an emphasis on T2D pathophysiology and molecular mechanisms, as well as holistic management for T2D based on the concept of MDS-related TOD
Please join with us today